ClinicalTrials.gg
CompletedNCT06865742Updated Nov 18, 2026

Music Therapy Applied During Hemodialysis

An interventional study of Music intervention in Hemodialysis, sponsored by Amasya University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Amasya University · Not applicable, Interventional, and Supportive care

How we know · 2 judgments

Updated Nov 18, 2026Now CompletedFirst site in Turkey (Türkiye)+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
58
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 332 studies in Fatigue with a site in Turkey — 50 open to participants now, 56 under way, none of them phase 3. Fatigue · Turkey.

Enrollment
131st of 252
58 · median 60
Started
2025
with 50 others
No phase
249 of 332
37 open now
Registered
211th of 332
by date

Among the 332 studies in Fatigue with a site in Turkey, this one is the 131st largest by enrollment of the 252 interventional ones that give a count, is one of 51 that started in 2025, is one of 249 with no phase, and was the 211th registered.

Fatigue

2,234 studies on the registry are indexed under Fatigue; 430 are open to participants now.

Browse Fatigue studies →

Open to participants now

50 of the 332 studies in Fatigue with a site in Turkey are open now. Recruiting first, the newest first:

45 more — sign in →

All 50 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 242 Fatigue studies recruiting now, 113 (47%) set no upper age limit and 99 (41%) stop at 75 or younger; 23 take children under 18; 74 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 332 studies in Fatigue with a site in Turkey, or all of them as a file.
02

Study summary

Many symptoms are encountered during the hemodialysis treatment process, and fatigue and insomnia are two of the most common symptoms. The management of these symptoms, which negatively affect the quality of life and mental well-being of individuals, is very important. It is known that the effects of pharmacological treatments are limited in the management of symptoms encountered during the HD treatment process, and the tendency towards non-pharmacological methods in symptom management is increasing.

This study will be conducted to determine the effects of music therapy to be applied to individuals receiving HD treatment on fatigue, sleep quality and mental well-being.

This randomized controlled experimental study will be conducted with 60 individuals receiving treatment in the hemodialysis clinic of a public hospital. Individuals will receive 30 minutes of music therapy after the 2nd hour of each hemodialysis session for 4 weeks. Research data will be collected using the Introductory Information Form, Chalder Fatigue Scale, Pittsburgh Sleep Quality Scale and Warwick-Edinburgh Mental Well-Being Scale.

This study is important because it is the first study to evaluate the effects of music therapy on fatigue, sleep quality and mental well-being of individuals receiving HD treatment. It is thought that music therapy applied to individuals receiving HD treatment will contribute to the literature on evidence.

Read the detailed description

Chronic renal failure (CKD) is a disease characterized by progressive and irreversible nephron loss that develops due to various diseases. In the CKD picture, permanent disorders are observed in the fluid-electrolyte balance and metabolic-endocrine functions of the kidney. Although CKD is a disease that can be prevented and/or its progression rate can be slowed down in the early stages, the low level of awareness about the disease and early diagnosis cause the disease to progress to the final stage, end-stage renal failure (ESRD).

Renal replacement therapies (RRT) such as dialysis and kidney transplantation are applied to individuals diagnosed with ESRD. Hemodialysis (HD) is the most commonly used RRT. The aim of HD treatment is to increase the life span and quality of life of individuals. However, it is known that HD, which is one of the life-preserving treatments, causes many undesirable problems in the physical, psychological, social and economic areas in addition to its targeted effects. Individuals who undergo HD encounter many problems such as diet and fluid restriction, job loss, early retirement, role changes and role losses, disruption in family life, dependence on devices and healthcare institutions, fear of death, depression, physical dysfunction, sexual dysfunction, decreased quality of life, and deterioration in body image and self-esteem. In addition, individuals during the treatment process; They also experience many symptoms such as fatigue, shortness of breath, pain, nausea-vomiting, loss of appetite, muscle cramps, insomnia, itching, drowsiness, irritability, dry skin, dizziness, and restlessness.

Fatigue and insomnia are two of the most common symptoms encountered during the HD treatment process. Fatigue, defined as an uncontrollable feeling of exhaustion, is intensely experienced by individuals receiving HD treatment. In the study by Hindistan and Deniz (2018), fatigue was detected in 83.5% of individuals, in the study by Usta and Demir (2014), in 52.2% of individuals before HD, 43.3% during HD, and 84.4% after HD, and in the study by Ju A et al. (2020), in 60-97% of individuals. It is known that fatigue in individuals receiving HD treatment causes an increase in the level of addiction, a decrease in physical activity level, and quality of life. Another problem that causes a decrease in quality of life and also increases the mortality rate is sleep problems. It has been reported that 60-85% of individuals receiving HD treatment have sleep problems. In the study of Taylan and Özkan (2020), it was determined that the sleep quality of individuals receiving HD treatment was low and 41.2% of the individuals had very poor sleep quality. Sleep problems include problems such as prolonged time to fall asleep, interruptions during sleep, daytime naps and restless leg syndrome.

All problems and symptoms encountered during the HD treatment process negatively affect the quality of life and mental well-being of individuals.The management of symptoms experienced in individuals receiving HD treatment is very important due to their effects on the quality of life and mental well-being. It is known that the effects of pharmacological treatments are limited in the management of symptoms encountered during the HD treatment process. Therefore, the tendency towards non-pharmacological methods in the management of these symptoms is increasing. Reducing symptoms in HD and ensuring the well-being of patients has an important place in terms of quality nursing care. For this reason, nurses can take a holistic approach to individuals receiving HD treatment and perform various interventions.In this context, nurses mostly prefer complementary treatments such as massage, aromatherapy, acupuncture, reflexology, and music therapy from non-pharmacological methods.

Music therapy is one of the important complementary treatments preferred by nurses and is a method used to provide symptom management and has no side effects.

03

Conditions studied

  • Hemodialysis

Keywords

  • Hemodialysis
  • Music Therapy
  • Fatigue
  • Sleep Quality
  • Mental Well-Being
  • nursing
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being 18 years of age or older
  • Being on HD treatment for at least 6 months
  • Being cooperative and having no verbal communication disabilities (hearing or speaking)
  • Not having a psychiatric disorder

Exclusion criteria

Exclusion Criteria:

  • Having recently attended a similar program
  • Not agreeing to participate in the study
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
58 participants (actual)

Study arms

  • Experimental
    Music therapy/Experimental group

    This group will receive music therapy for 30 minutes after the 2nd hour of each hemodialysis session for 4 weeks.

    Behavioral: Music intervention

  • No intervention
    Control group

    No intervention will be performed in this group. Individuals will receive their routine care.

Interventions

  • BehavioralMusic intervention

    This is the first study to evaluate the effects of music therapy on fatigue, sleep quality and mental well-being of individuals receiving HD treatment.

06

What researchers measure

Primary outcomes

  1. Is music therapy effective in reducing fatigue?

    The scale is a 4-point Likert type. The physical fatigue subscale score and the mental fatigue subscale score of the scale are added to obtain the general fatigue score. The physical fatigue subscale score can vary between 0-21, the mental fatigue subscale score between 0-12, and the total fatigue score between 0-33. An increase in the scale score indicates an increase in fatigue severity.

    Time frame: Baseline and week 4

  2. Is music therapy effective in improving sleep quality?

    The scale evaluates sleep quality in the last month. It consists of 19 questions and seven subscales, and 18 items are included in the scoring. Each item is evaluated on a 0-3 scale, and the total scale score is the sum of the seven subscale scores. The total score that can be obtained from the scale varies between 0-21, with a high score indicating poor sleep quality. A total scale score of ≤5 indicates "good sleep", and a score of \>5 indicates "bad sleep".

    Time frame: Baseline and week 4

  3. Is music therapy effective in improving mental well-being?

    The scale consists of 14 items and is a 5-point Likert type. Scores range from 14 to 70. High scores indicate high psychological well-being.

    Time frame: Baseline and week 4

07

Study locations

1 site
  • Amasya University
    Amasya, Amasya 5100, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — There is not a plan to make IPD available.

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2025 to primary completion in Dec 2025, 1 month.

Of 937 non-industry interventional studies with no phase under Fatigue, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's 1 month is below that.

Counting every sponsor, half of 990 studies reached it within 12 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 12, 2025
First posted
Mar 10, 2025
StartActual
Nov 3, 2025
Primary completionActual
Dec 31, 2025
CompletionActual
Dec 31, 2025
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Completed
changed Nov 2, 2026
Sites
1 site added — first site in Turkey (Türkiye)
Show site
  • Amasya University · Amasya, Turkey (Türkiye)
Nov 2, 2026
Primary completion
Dec 5, 2025→Dec 31, 2025 (actual)
Nov 2, 2026
Enrollment
60 (estimated)→58
Nov 18, 2026
Show all 2 updates
  1. Nov 18, 2026
    Enrollment 52→58
  2. Nov 2, 2026
    Not yet recruiting→Completed
    1 site added — first site in Turkey (Türkiye)
    Show site
    • Amasya University · Amasya, Turkey (Türkiye)
    Primary completion Dec 5, 2025→Dec 31, 2025 (now actual)
    Enrollment 60 (estimated)→52 (actual)
    + 3 other changes: verification date, oversight details and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06865742
Lead sponsor
Amasya University
Collaborators
Erzurum Technical University
Responsible party
Sponsor
First posted
Mar 10, 2025
Start date
Nov 3, 2025
Primary completion
Dec 31, 2025
Completion
Dec 31, 2025
Last update
Nov 18, 2026

Study contacts

Şeyda Karasu, RA
study chair · Erzurum Technical University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion